Department of Pediatrics, Division of Neonatology, Center for Perinatal Biology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Circulation. 2011 Feb 15;123(6):605-12. doi: 10.1161/CIRCULATIONAHA.110.001073. Epub 2011 Jan 31.
Nitrite can be converted to nitric oxide (NO) by a number of different biochemical pathways. In newborn lambs, an aerosol of inhaled nitrite has been found to reduce pulmonary blood pressure, possibly acting via conversion to NO by reaction with intraerythrocytic deoxyhemoglobin. If so, the vasodilating effects of nitrite would be attenuated by free hemoglobin in plasma that would rapidly scavenge NO.
Pulmonary vascular pressures and resistances to flow were measured in anesthetized newborn lambs. Plasma hemoglobin concentrations were then elevated, resulting in marked pulmonary hypertension. This effect was attenuated if infused hemoglobin was first oxidized to methemoglobin, which does not scavenge NO. These results further implicate NO as a tonic pulmonary vasodilator. Next, while free hemoglobin continued to be infused, the lambs were given inhaled NO gas (20 ppm), inhaled sodium nitrite aerosol (0.87 mol/L), or an intravascular nitrite infusion (3 mg/h bolus, 5 mg · kg⁻¹ · h⁻¹ infusion). Inhaled NO and inhaled nitrite aerosol both resulted in pulmonary vasodilation. Intravascular infusion of nitrite, however, did not. Increases in exhaled NO gas were observed in lambs while breathing the nitrite aerosol (≈ 20 ppb NO) but not during intravascular infusion of nitrite.
We conclude that the pulmonary vasodilating effect of inhaled nitrite results from its conversion to NO in airway and parenchymal lung tissue and is not dependent on reactions with deoxyhemoglobin in the pulmonary circulation. Inhaled nitrite aerosol remains a promising candidate to reduce pulmonary hypertension in clinical application.
亚硝酸盐可以通过多种不同的生化途径转化为一氧化氮(NO)。在新生羔羊中,吸入亚硝酸酯气雾剂已被发现可降低肺血压,其作用机制可能是通过与红细胞内的脱氧血红蛋白反应转化为 NO。如果是这样,血浆中的游离血红蛋白会迅速清除 NO,从而减弱亚硝酸盐的血管舒张作用。
在麻醉的新生羔羊中测量肺血管压力和血流阻力。然后升高血浆血红蛋白浓度,导致明显的肺动脉高压。如果先将输入的血红蛋白氧化为高铁血红蛋白(不能清除 NO),则会减轻这种作用。这些结果进一步表明 NO 是一种具有紧张性的肺血管舒张剂。接下来,在继续输入游离血红蛋白的同时,给羔羊吸入 NO 气体(20ppm)、吸入亚硝酸钠气雾剂(0.87mol/L)或静脉内输注亚硝酸盐(3mg/h 推注,5mg·kg⁻¹·h⁻¹输注)。吸入 NO 和吸入亚硝酸钠气雾剂均导致肺血管舒张。然而,静脉内输注亚硝酸盐并没有。在羔羊吸入亚硝酸酯气雾剂(≈20ppbNO)时观察到呼气中 NO 气体增加,但在静脉内输注亚硝酸盐时没有。
我们的结论是,吸入亚硝酸酯的肺血管舒张作用是由于其在气道和肺实质组织中转化为 NO,而与肺循环中的脱氧血红蛋白反应无关。吸入亚硝酸酯气雾剂仍然是一种有前途的候选药物,可在临床应用中降低肺动脉高压。